Novo Integrated Sciences, through its wholly owned subsidiary, Novo Healthnet Limited (NHL), delivers multidisciplinary primary health care related services and products through the integration of medical technology, interconnectivity, improved therapeutics, diagnostic solutions, personalized product offerings, and rehabilitative science. Co.'s clinicians and practitioners provide certain multidisciplinary primary health care services, and related products. NHL's team of multidisciplinary primary health care clinicians and practitioners provide assessment, diagnosis, education and primary prevention for an array of orthopedic, musculoskeletal, sports injury, and neurological conditions. The NVOS YTD return is shown above.
The YTD Return on the NVOS YTD return page and across the coverage universe of our site,
is a measure of the total return for a given investment year-to-date for the current calendar year
(up to the end of prior trading session). Arguably, choosing the current calendar year for a measurement
period is on the one hand completely arbitrary, but on the other hand a year-to-date look can be extremely
useful in the context of our country's tax system which taxes gains and income on a calendar year basis.
Thus, researching Year-To-Date Returns is good practice for investors — whether NVOS YTD return or other benchmarks/peers
— and when doing so it is also important to factor in dividends, because a financial instrument's YTD return is
more than just the change in price if that instrument pays a dividend or coupon. Our website aims to empower investors
by performing the NVOS YTD return calculation (with any dividends reinvested as applicable), and to provide a
coverage universe of many stocks and ETFs to be able to compare YTD returns.
|